SALUDA MEDICAL, INC. ARBN 691 140 360 9401 James Ave S, Suite 132 Bloomington MN 55431, United States 1 ASX ANNOUNCEMENT 7 September 2026 Saluda Medical CEO Transition Saluda Medical, Inc. (ASX:SLD, “Saluda” or the “Company”), today announced the Board has appointed Mr Mike Mathias, who...
CEO Transition
Filed with ASX ·
On 6ix: 6ix.com/news/ceo-transition-32
6ix hasn’t read this filing yet.
Earlier from Saluda Medical
- S&P DJI Announces September 2026 Quarterly Rebalance
- Change in substantial holding
- FY26 Results Presentation
- FY26 Full Year Results
- Preliminary Final Report
Later from Saluda Medical
- FY26 Consolidated Financial Statements
- Final Director's Interest Notice - B Regan
- Director Appointment/Resignation
- Initial Director's Interest Notice
- Expands Access with Full US Commercial Release of CAP24
Follow Saluda Medical into a list and get an email when it puts out news.
Follow Saluda Medical